![Alwyn Mwinga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alwyn Mwinga
Directeur/Bestuurslid bij Drugs for Neglected Diseases initiative
Actieve functies van Alwyn Mwinga
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Directeur/Bestuurslid | - | - |
Loopbaan van Alwyn Mwinga
Opleiding van Alwyn Mwinga
University of London | Graduate Degree |
University of Zambia | Graduate Degree |
Statistieken
Internationaal
Zwitserland | 2 |
Verenigd Koninkrijk | 2 |
Zambia | 2 |
Operationeel
Graduate Degree | 2 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Drugs for Neglected Diseases initiative
![]() Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
- Beurs
- Insiders
- Alwyn Mwinga
- Ervaring